BB some of your links are informative. Previous to reading these...

BB some of your links are informative. Previous to reading these I wondered if the terminating of some global patent for provale below was strategically good for all shareholders. Below is from the MD's report. I am a holder of sti and aim to keep an open mind however in doing so I have questioned a few things lately.


The majority of the global patent process for ProVale has also been
terminated as the nature of the product and its proprietary method of manufacture
makes it difficult to protect, and very costly. These initiatives will see the Company save
approximately $500,000 over the current year on its prior committed IP expenditure
budget